This test is most useful if any of these apply to you.
Insulin resistance can build quietly. Your pancreas makes more insulin to keep blood sugar normal, and for years it may succeed. A routine fasting glucose test can look fine while the system is under strain.
HOMA-IR estimates how hard that system is working. It is a practical early signal for the biology that can lead to type 2 diabetes, heart disease, and fatty liver, but it is not a diagnosis by itself. You get it from a fasting blood draw.
HOMA-IR is a calculation, not a substance in your blood. The full name is Homeostatic Model Assessment of Insulin Resistance. A lab measures two things after an overnight fast: your blood glucose and your insulin. Insulin resistance means your cells respond weakly to insulin, so the pancreas has to release more of it to get the same job done. When both fasting glucose and fasting insulin run high, the score climbs.
The score mainly reflects insulin resistance in the fasting state, where the liver matters a lot. It is a stand-in for a research reference method that holds blood sugar steady while measuring insulin action. That procedure is slow and expensive, so it is rarely used outside studies. HOMA-IR trades some precision for the fact that you can actually get it done.
There is no universal cutoff. What counts as concerning depends on age, sex, body weight, ancestry, and the specific insulin assay a lab uses. Research cutoffs vary widely across populations, even when investigators are trying to describe roughly the same biology.
So treat HOMA-IR as a metabolic signal, not a pass-fail line. The most useful comparison is your own number over time, read alongside the rest of your metabolic picture. A value that looks unremarkable in isolation can still matter if it is rising, and a modestly high one can be less alarming if everything else is clean. The direction and the context carry the meaning, not the single digit.
A higher HOMA-IR can show metabolic strain before fasting glucose or HbA1c cross diabetes lines. In a pooled analysis of adults with metabolic risk factors, those with high HOMA-IR had nearly twice the risk of developing type 2 diabetes. In a long Korean cohort of adults without diabetes, high HOMA-IR predicted new-onset diabetes even after accounting for baseline HbA1c.
This is the practical value of the test. Fasting glucose and HbA1c tell you where your blood sugar is now. HOMA-IR tells you how much strain the system is already under, which is the part that often moves first.
Insulin resistance is tied to cardiovascular risk before blood sugar crosses a diabetes line. A meta-analysis pooling 65 studies and 516,325 people found that high HOMA-IR carried about 64% higher risk of coronary heart disease, and it tracked heart risk better than fasting glucose or fasting insulin measured alone.
The trajectory matters more than any one reading. In adults followed over time, those whose HOMA-IR climbed had roughly 60% higher risk of a first cardiovascular event and more than double the risk of dying from one. In younger adults tracked for three decades, a persistently high HOMA-IR path meant more than triple the stroke risk. The risk is not spread evenly, though. In a very large nationwide study, the link between HOMA-IR and heart disease was strongest in people who already had prediabetes or diabetes, and weakest in those with normal glucose.
Rising insulin resistance also tracks with declining kidney function. In more than five thousand adults, those whose HOMA-IR increased over time had a higher risk of adverse kidney outcomes after accounting for other factors, and the link held whether or not they had diabetes. It is one more reason the trend is worth watching rather than a single snapshot.
Insulin resistance is common in polycystic ovary syndrome, though not everyone with PCOS has it. It can show up even without extra weight. In one observational study of women with PCOS, HOMA-IR flagged more insulin resistance than fasting insulin alone.
The signal extends into pregnancy, but the evidence is more situation-specific. Higher HOMA-IR before IVF or ICSI embryo transfer was linked to nearly four times the odds of late miscarriage in women without PCOS or lipid problems. In gestational diabetes, higher insulin resistance was associated with high blood pressure in pregnancy and larger babies, though it did not predict every complication. In early pregnancy it is only a moderate predictor of gestational diabetes, and useful thresholds shift with body weight.
HOMA-IR is noisier than most people assume, and a single value can mislead. In a study that measured the same healthy people ten weeks in a row, HOMA-IR varied by about 27% within a person, mostly from natural week-to-week variation in insulin. That alone is a strong argument against reading too much into one draw.
Because a single HOMA-IR can bounce around by roughly a quarter, the trend carries more weight than one reading. One result gives you a rough placement. A series tells you which way your metabolism is heading and whether a diet, weight, or medication change is taking hold.
HOMA-IR works best when it agrees with the rest of the pattern. High triglycerides, low HDL, and weight carried around the middle alongside a rising HOMA-IR all point the same direction and make the insulin resistance picture more consistent.
If fasting glucose and HbA1c still look normal but suspicion is strong, a glucose tolerance test that also measures insulin can reveal resistance that a fasting number misses. The triglyceride-to-glucose index is a cheaper companion signal that sometimes tracks these outcomes as well or better. A clearly rising HOMA-IR clustered with other metabolic findings is worth acting on. An isolated, mildly elevated value with an otherwise clean profile is mainly a reason to confirm the trend.
Evidence-backed interventions that affect your HOMA-IR level
HOMA-IR is best interpreted alongside these tests.
HOMA-IR is included in these pre-built panels.